The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efbemalenograstim alfa for the primary/secondary prophylaxis of intermediate-risk febrile neutropenia (FN) chemotherapy regimen with risk factors in patients with non-small cell lung cancer (NSCLC): A randomized, multicenter, exploratory clinical trial.
 
Mengjie Li
No Relationships to Disclose
 
Dingzhi Huang
No Relationships to Disclose
 
Tianhui Gao
No Relationships to Disclose
 
Caixia Liu
No Relationships to Disclose
 
Haitao Lan
No Relationships to Disclose
 
Jun Ge
No Relationships to Disclose
 
Wei Zheng
No Relationships to Disclose
 
Xiaoyong Tang
No Relationships to Disclose
 
Chuangzhou Rao
No Relationships to Disclose